STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLX
  4. [Form 4] CLOROX CO /DE/ Insider Trading Activity

CLOROX (CLX) adds 212.8954 DSUs, now 5,413.1984 shares

Clorox director Stephanie Plaines reported two grants of Deferred Stock Units (DSUs) that increase her beneficial ownership.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clorox director Stephanie Plaines reported two grants of Deferred Stock Units (DSUs) that increase her beneficial ownership. On 08/29/2025 she received 53.9884 DSUs through dividend reinvestment, and on 09/30/2025 she received 212.8954 DSUs in lieu of quarterly director fees. The filing shows the DSUs will be settled 100% in Clorox common stock upon the reporting person’s retirement or other termination, and total reported beneficial ownership after the transactions is 5,413.1984 shares (previously 5,200.303).

Positive

  • Director holdings increased by 212.8954 DSUs on 09/30/2025, raising total to 5,413.1984 shares
  • DSUs settled 100% in common stock, aligning director compensation with shareholder outcomes upon termination

Negative

  • None.

Insights

Routine director compensation increased holdings modestly via DSUs.

What it means: The report documents standard deferred-compensation mechanics: 53.9884 DSUs from dividend reinvestment and 212.8954 DSUs received in lieu of fees, raising total reported beneficial ownership to 5,413.1984 shares.

Why it matters: These are non-cash, non-exercisable units that convert to common stock on termination, so they slightly increase potential future dilution and align director pay with shareholder outcomes without immediate share issuance.

Insider Plaines Stephanie
Role Director
Type Security Shares Price Value
Grant/Award Deferred Stock Units 212.8954 $0.00 $0.00
Grant/Award Deferred Stock Units 53.9884 $0.00 $0.00
Holdings After Transaction: Deferred Stock Units — 5,413.1984 contracts (Direct)
Footnotes (4)
  1. F1. 1-for-1
  2. F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
  3. F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
  4. F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

FAQ

What transactions did Stephanie Plaines report on the Form 4 for CLX?
Two grants of Deferred Stock Units: 53.9884 DSUs on 08/29/2025 (dividend reinvestment) and 212.8954 DSUs on 09/30/2025 (fees in lieu).

How many shares does the Form 4 show Stephanie Plaines beneficially owns after the transactions?
The filing reports 5,413.1984 shares beneficially owned following the reported transactions.

How and when will the Deferred Stock Units be settled?
The DSUs will be settled 100% in Clorox common stock in connection with the reporting person's retirement or other termination of service.

Why were DSUs received on 08/29/2025 and 09/30/2025?
08/29/2025: DSUs from dividend reinvestment under the Independent Directors' Deferred Compensation Plan. 09/30/2025: DSUs received in lieu of quarterly director's fees.

Who signed the Form 4 filing for Stephanie Plaines?
The form was filed by attorney-in-fact Jinho Joo and signed on 10/02/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Plaines Stephanie
(Last) (First) (Middle)
1221 BROADWAY
(Street)
OAKLAND CA 94612-1888
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 08/29/2025 A(2) V 53.9884 (3) (3) Common Stock 53.9884 $0.0000 5,200.303 D
Deferred Stock Units (1) 09/30/2025 A(4) 212.8954 (3) (3) Common Stock 212.8954 $0.0000 5,413.1984 D
Explanation of Responses:
1. 1-for-1
2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
By Jinho Joo, Attorney-in-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

Keep reading

More on CLX

Trending in the feed

Open the live feed